v3.25.2
ACQUISITIONS
 6 Months Ended
Jun. 30, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
ACQUISITIONS ACQUISITIONS
We are required to allocate the purchase prices of acquired businesses to assets acquired or liabilities assumed and, if applicable, noncontrolling interests based on their fair values. The excess of the purchase price allocated over those fair values is recorded as goodwill. The purchase price allocations for certain acquisitions completed in 2025 and 2024 are preliminary. We are in the process of assessing working capital balances and lease and other agreements assumed, as well as obtaining and evaluating valuations of the acquired property and equipment, management contracts and other intangible assets, and noncontrolling interests. Therefore, those purchase price allocations, including goodwill, recorded in the accompanying Condensed Consolidated Financial Statements are subject to adjustment once the assessments and valuation work are completed and evaluated. Such adjustments will be recorded as soon as practical and within the measurement period as defined by the accounting literature.
Preliminary purchase price allocations (representing the fair value of the consideration conveyed) for all acquisitions made during the six months ended June 30, 2025 and 2024 were as follows:
Six Months Ended June 30,
20252024
Current assets$35 $67 
Property and equipment22 42 
Other intangible assets5 132 
Goodwill255 820 
Long-term operating lease assets73 99 
Other long-term assets— 1 
Previously held investments in unconsolidated affiliates(70)(23)
Current liabilities(35)(67)
Long-term operating lease liabilities(69)(88)
Other long-term liabilities(6)(12)
Redeemable noncontrolling interests in equity of consolidated subsidiaries(72)(381)
Noncontrolling interests(33)(59)
Cash paid, net of cash acquired(138)(500)
Gains (losses) on consolidations$(33)$31 
The goodwill generated from our 2025 acquisitions, the majority of which we believe will not be deductible for income tax purposes, can be attributed to the benefits that we expect to realize from operating efficiencies and growth strategies. Goodwill recognized related to our acquisition activity during the six months ended June 30, 2025 was entirely attributable to our Ambulatory Care segment.
During the six months ended June 30, 2025, we adjusted the preliminary purchase price allocations of certain acquisitions completed by our Ambulatory Care segment in 2024 based on the results of completed valuations and post-closing working capital adjustments. These adjustments resulted in a net increase in cash paid for the acquired entities of $9 million and a decrease in goodwill of $11 million.